Matthew Norkunas

Matt was previously chief financial officer at SomaLogic, Inc., a Colorado-based biotech. In that role, he helped lead a complete strategic overhaul for the company, closed several large business development deals and oversaw strong commercial growth both in the U.S. and overseas. Prior, Matt served as senior equity analyst at Marsico Capital Management, where he was the firm’s primary health care investment specialist. Matt began his career as a practicing anesthesiologist. He earned a Master of Business Administration from Columbia Business School, a medical degree from University of Maryland School of Medicine, and a Bachelor of Arts degree from St. Mary’s College of Maryland.